Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas
- PMID: 1524803
- DOI: 10.1007/BF00714485
Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas
Abstract
The expression of the receptor for epidermal growth factor (EGF) has been determined on oral squamous cell carcinomas. Immunoreactive receptor was localized using a monoclonal anti-EGF-receptor antibody which reacts with sequences in the external domain of the receptor. Frozen sections were studied from 40 patients with squamous cell carcinomas. In 16 sections from the patients with the squamous cell carcinomas, normal differentiated oral mucosa was included and in 7 of these the patients had received preoperative radiotherapy. Sections from 6 other patients with squamous cell carcinoma contained dysplastic epithelia. EGF-receptor-positive cells were present in the basal cell layer on normal differentiated oral mucosa. In sections from patients receiving preoperative radiotherapy the EGF-receptor-positive cells were also found in the spinous cells. In dysplastic epithelia nearly all cells stained for the receptor. The distribution and staining intensity of the EGF receptor varied in the oral squamous cell carcinomas, 36 were positive. The staining pattern in the carcinomas obtained from patients receiving preoperative radiotherapy was not altered qualitatively. Nearly all poorly differentiated cells were stained, but when the tumor was moderately to well differentiated a reduction in the extent of staining in certain areas was seen, paralleling the findings observed in the differentiated upper layers of the normal oral mucosa. This was most pronounced for the epithelial pearls, where the EGF-receptor-positive cells were localized to the undifferentiated cells in the periphery. The results of the present investigation confirm the presence of the EGF receptor on undifferentiated cells, with the extent of the staining reaction on oral squamous cell carcinomas varying inversely with cellular differentiation.
Similar articles
-
Immunohistochemical detection of epidermal growth factor receptor in laryngeal squamous cell carcinomas.Acta Otolaryngol. 1992;112(4):734-8. doi: 10.3109/00016489209137467. Acta Otolaryngol. 1992. PMID: 1442018
-
Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas.J Pathol. 1993 Mar;169(3):323-8. doi: 10.1002/path.1711690308. J Pathol. 1993. PMID: 8492225
-
The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.Dan Med Bull. 1998 Apr;45(2):121-34. Dan Med Bull. 1998. PMID: 9587699 Review.
-
Evaluation of epidermal growth factor receptor in squamous cell carcinoma of the oral cavity.Oral Surg Oral Med Oral Pathol. 1992 Jan;73(1):67-70. doi: 10.1016/0030-4220(92)90157-l. Oral Surg Oral Med Oral Pathol. 1992. PMID: 1603568
-
Microbial Colonization and Inflammation as Potential Contributors to the Lack of Therapeutic Success in Oral Squamous Cell Carcinoma.Front Oral Health. 2021 Oct 4;2:739499. doi: 10.3389/froh.2021.739499. eCollection 2021. Front Oral Health. 2021. PMID: 35048056 Free PMC article. Review.
Cited by
-
Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis.Head Neck Oncol. 2010 Jun 25;2:13. doi: 10.1186/1758-3284-2-13. Head Neck Oncol. 2010. PMID: 20579333 Free PMC article.
-
Immunolocalization of transforming growth factor alpha in normal human tissues.Histochem Cell Biol. 1996 May;105(5):391-400. doi: 10.1007/BF01463660. Histochem Cell Biol. 1996. PMID: 8781993
-
[Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy].HNO. 2005 Mar;53(3):285-97; quiz 298. doi: 10.1007/s00106-004-1167-0. HNO. 2005. PMID: 15759168 Review. German.
-
Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?Biomark Cancer. 2013 Oct 10;5:49-60. doi: 10.4137/BIC.S12951. Biomark Cancer. 2013. PMID: 24179398 Free PMC article. Review.
-
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.Ann Oncol. 2011 May;22(5):1078-1087. doi: 10.1093/annonc/mdq588. Epub 2010 Nov 3. Ann Oncol. 2011. PMID: 21048039 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials